Get started
Author

Myriam Ben-Neji

Observed names: Ben-Neji, Myriam, M. Ben-Neji, Myriam Ben Neji
ORCID: 0009-0008-7414-349X
Observed ORCID: 0009-0008-7414-349X
OpenAlex ID: A5069127296
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages
2020 · Maeva Dupont, Shanti Souriant, et al. · eLife · 75
The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2018 · Philippe Gui, Myriam Ben-Neji, et al. · Cancer Immunology Research · 44
Genetic engineering of Hoxb8-immortalized hematopoietic progenitors – a potent tool to study macrophage tissue migration
2020 · Solene Accarias, Thibaut Sanchez, et al. · Journal of Cell Science · 25
PDF
Moesin controls cell–cell fusion and osteoclast function
2025 · Ophélie Dufrançais, Marianna Plozza, et al. · The Journal of Cell Biology · 13
Surface-anchored carbon nanomaterials for antimicrobial surfaces
2024 · L. Giraud, O. Marsan, et al. · Nanoscale · 7
PDF
HIV-1 Tat favors the multiplication of Mycobacterium tuberculosis and Toxoplasma by inhibiting clathrin-mediated endocytosis and autophagy
2025 · Aurélie Rivault, Audrey Bernut, et al. · PLoS Pathogens · 3
PDF
Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages
2026 · Zoï Vahlas, Clara Deyts, et al. · Life Science Alliance · 2
PDF
Author response: Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages
2020 · Maeva Dupont, Shanti Souriant, et al. · eLife · 1
Author Reply to Peer Reviews of Inhibition of glycolysis in tuberculosis-mediated metabolic rewiring reduces HIV-1 spread across macrophages
2024 · Zoi Vahlas, Natacha Faivre, et al.
Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplemental Table 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplemental Table 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
PDF
Supplemental figure 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplemental figure 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
PDF
Supplementary Data from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Video 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Video 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplemental figure 3 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
PDF
Video 2 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplementary Fig S4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
PDF
Supplementary Fig S5 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
PDF
Video 1 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Video 4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Supplementary Fig S4 from The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy
2023 · Philippe Gui, Myriam Ben-Neji, et al.
Works count: 34
Citation count: 170
H-index: 5
I10-index: 4
Year
Topic
Type